ARGENE announce the release of a new real-time PCR range of products for the detection and/or the quantification of the novel 2009 Influenza A(H1N1)The recent emergence of the novel 2009 Influenza A(H1N1) and the fast global spread of this virus highlights the urgent need for a reliable diagnostic assay to readily implement into daily routine.
Being aware of our responsibility as a key player in the domain of In Vitro Diagnostics, we immediately reacted and decided to develop a Real Time PCR assay for the diagnosis of novel 2009 Influenza A(H1N1).
Argene mobilized a dedicated team with the aim to develop a diagnostic molecular assay for the detection and/or quantification of this virus... ARGENE's Press Release - Communiqué de Presse d'ARGENE -
About Argene Biosoft
THE IN VITRO DIAGNOSTIC INDUSTRY
As a key partner of public and private medical biological analysis laboratories, the in vitro diagnostics industry provides the reagents and materials required for the analysis of blood, urine, cerebrospinal fluid or any other biological sample.
ARGENE specialises in this domain and offers products and reagents for the detection of infectious agents in laboratories. These tests may be carried out for diagnostic or preventive purposes, but also as part of the follow-up of certain treatments... About Argene - A propos d'Argene Biosoft -
